Our Science – Baird Website
Kristin Baird, M.D.
Selected Publications |
 |
| 1)
Wiener L, Zadeh S, Battles H, Baird K, Ballard E, Osherow J, Pao M. Allowing Adolescents and Young Adults to Plan Their End-of-Life Care. Pediatrics. 2012. [Journal] |
|
| 2)
Grkovic L, Baird K, Steinberg SM, Williams KM, Pulanic D, Cowen EW, Mitchell SA, Hakim FT, Martires KJ, Avila DN, Taylor TN, Salit RB, Rowley SD, Zhang D, Fowler DH, Bishop MR, Gress RE, Pavletic SZ. Clinical laboratory markers of inflammation as determinants of chronic graft-versus-host disease activity and NIH global severity. Leukemia. 26: 633-43, 2012. [Journal] |
|
| 3)
van Den Brink M, Leen AM, Baird K, Merchant M, Mackall C, Bollard CM. Enhancing Immune Reconstitution - from Bench to Bedside. Biol. Blood Marrow Transplant. 2012. [Journal] |
|
| 4)
Kitko CL, White ES, Baird K. Fibrotic and sclerotic manifestations of chronic graft-versus-host disease. Biol. Blood Marrow Transplant. 18: S46-52, 2012. [Journal] |
|
| 5)
Kesserwan C, Sokolic R, Cowen EW, Garabedian E, Heselmeyer-Haddad K, Lee CC, Pittaluga S, Ortiz C, Baird K, Lopez-Terrada D, Bridge J, Wayne AS, Candotti F. Multicentric dermatofibrosarcoma protuberans in patients with adenosine deaminase-deficient severe combined immune deficiency. J. Allergy Clin. Immunol. 129: 762-769.e1, 2012. [Journal] |
|
| 6)
Shah NN, Bacher U, Fry T, Calvo KR, Stetler-Stevenson M, Arthur DC, Kurlander R, Baird K, Wise B, Giralt S, Bishop M, Hardy NM, Wayne AS. Myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation: Diagnostic and therapeutic challenges. Am. J. Hematol. 87: 916-22, 2012. [Journal] |
|
| 7)
Fassil H, Bassim CW, Mays J, Edwards D, Baird K, Steinberg SM, Williams KM, Cowen EW, Mitchell SA, Hakim FT, Taylor T, Avila D, Zhang D, Grkovic L, Datiles M, Gress RE, Pavletic SZ. Oral chronic graft-vs.-host disease characterization using the NIH scale. J. Dent. Res. 91: 45S-51S, 2012. [Journal] |
|
| 8)
Merchant MS, Geller JI, Baird K, Chou AJ, Galli S, Charles A, Amaoko M, Rhee EH, Price A, Wexler LH, Meyers PA, Widemann BC, Tsokos M, Mackall CL. Phase I Trial and Pharmacokinetic Study of Lexatumumab in Pediatric Patients With Solid Tumors. J. Clin. Oncol. 2012. [Journal] |
|
| 9)
Bassim CW, Ambatipudi KS, Mays JW, Edwards DA, Swatkoski S, Fassil H, Baird K, Gucek M, Melvin JE, Pavletic SZ. Quantitative Salivary Proteomic Differences in Oral Chronic Graft-versus-Host Disease. Journal of clinical immunology. 2012. [Journal] |
|
| 10)
Mitchell SA, Jacobsohn D, Thormann Powers KE, Carpenter PA, Flowers ME, Cowen EW, Schubert M, Turner ML, Lee SJ, Martin P, Bishop MR, Baird K, Bolaños-Meade J, Boyd K, Fall-Dickson JM, Gerber LH, Guadagnini JP, Imanguli M, Krumlauf MC, Lawley L, Li L, Reeve BB, Clayton JA, Vogelsang GB, Pavletic SZ. A Multicenter Pilot Evaluation of the National Institutes of Health Chronic Graft-versus-Host Disease (cGVHD) Therapeutic Response Measures: Feasibility, Interrater Reliability, and Minimum Detectable Change. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2011. [Journal] |
|
| Click Here to View Expanded Bibliography. |
This page was last updated on 10/23/2012.
